Aeon Biopharma, INC. (AEON) SEC Filings — 2025
23 SEC filings for Aeon Biopharma, INC. (AEON) in 2025.
Filings
- AEON Biopharma Seeks Shareholder Nod for Critical Financing, Equity Deals — DEF 14A · Dec 29, 2025
- AEON Biopharma Files 8-K: Agreements, Equity Sales — 8-K · Dec 15, 2025
- AEON Biopharma Files 8-K: Reg FD & Financials — 8-K · Dec 4, 2025
- AEON Biopharma Narrows Loss, Pivots to Biosimilar Strategy — 10-Q · Nov 14, 2025
- AEON Biopharma Files 8-K on Agreements and Equity Sales — 8-K · Nov 13, 2025
- AEON Biopharma Files 8-K — 8-K · Sep 8, 2025
- AEON Shifts Strategy to Biosimilar, Reports Q2 Loss Amid Cash Infusion — 10-Q · Aug 12, 2025
- AEON Biopharma Files 8-K on Shareholder Vote Matters — 8-K · Jun 13, 2025
- AEON Biopharma Amends 2024 10-K, Maintains Emerging Growth Status — 10-K/A · Jun 11, 2025
- AEON Biopharma Files 8-K with Financials — 8-K · May 20, 2025
- AEON Biopharma Files 10-Q for Q1 2025 — 10-Q · May 14, 2025
- AEON Biopharma Files 2024 Proxy Statement — DEF 14A · Apr 29, 2025
- AEON Biopharma Faces Delisting Concerns — 8-K · Apr 25, 2025
- AEON Biopharma Announces Director & Officer Changes — 8-K · Apr 21, 2025
- AEON Biopharma Announces Board and Officer Changes — 8-K · Apr 8, 2025
- AEON Biopharma Files 8-K on Director Changes & Compensation — 8-K · Mar 27, 2025
- AEON Biopharma Files 2024 10-K, Details Financials — 10-K · Mar 24, 2025
- AEON Biopharma Files 8-K for Reg FD and Financials — 8-K · Mar 10, 2025
- AEON Biopharma Files 8-K on Corporate Actions — 8-K · Feb 24, 2025
- AEON Biopharma Faces Delisting Concerns — 8-K · Feb 7, 2025
- AEON Biopharma Files Definitive Proxy Statement — DEF 14A · Jan 23, 2025
- AEON Biopharma Files Current Report on Form 8-K — 8-K · Jan 7, 2025
- AEON Biopharma Files 8-K — 8-K · Jan 6, 2025